Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
Italy flag Italy · Delayed Price · Currency is EUR
1.125
+0.005 (0.45%)
At close: Jul 28, 2026

BIT:ERFO Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9.969.966.345.425.025.1
Revenue Growth
21.17%57.11%16.96%8.02%-1.71%21.54%
Gross Profit
12.912.98.013.863.73.73
Operating Income
0.990.990.520.791.041.57
Net Income
0.310.380.370.580.751.16
Earnings Per Share
0.040.040.040.070.080.77
EPS Growth
0.08%11.57%-42.86%-12.50%-89.63%-

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Network
7.867.864.624.743.954.13
Direct
1.091.090.850.70.50.6
Medical
0.410.410.310.240.120.05
Other
0.670.670.560.580.460.34
Total
10.0310.036.346.265.035.13

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.440.440.320.761.460.37
Total Debt
1.351.350.380.450.580.74
Net Cash (Debt)
-0.91-0.91-0.060.310.88-0.37
Net Cash Growth
----64.88%--
Net Cash Per Share
-0.11-0.11-0.010.030.10-0.25

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
0.920.921.241.270.692.24
Capital Expenditures
-0.03---0.3-0.42-0.18
Free Cash Flow
0.890.921.240.960.272.06
Free Cash Flow Growth
-17.07%-25.97%28.84%251.48%-86.72%57.03%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
129.50%129.50%126.43%71.19%73.71%73.15%
Operating Margin
9.96%9.96%8.26%14.66%20.68%30.74%
Pretax Margin
10.47%10.47%8.30%14.31%19.92%30.27%
Profit Margin
7.40%7.40%5.57%10.76%15.03%22.68%
FCF Margin
8.93%9.23%19.58%17.77%5.46%40.41%

Dividends

Fiscal YearFY 2023FY 2022
Period EndingDec '23 Dec '22
Dividend Per Share
0.060-
Dividend Per Share Growth
--
Dividend Yield
1.41%3.01%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13.0132.9431.6318.7125.38-
Forward PE
-12.7819.4613.1012.30-
P/FCF Ratio
11.2713.648.7011.7066.67-
PS Ratio
0.981.261.702.083.64-